Literature DB >> 35577444

Pacemaker-induced endocarditis by Gordonia bronchialis.

Saray Mormeneo Bayo1, María Pilar Palacián Ruíz2, Uxua Asin Samper3, María Isabel Millán Lou2, Ascensión Pascual Catalán3, María Cruz Villuendas Usón2.   

Abstract

PURPOSE: Gordonia species are known to be opportunistic human pathogens causing secondary infections. We present the second case in the world of endocarditis caused by Gordonia bronchialis and a review of all the cases of endocarditis caused by Gordonia spp.
METHODS: The identification was performed by matrix-assisted desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and 16S rRNA gene sequencing were performed to confirm the identification. Antimicrobial susceptibility was performed by MIC test Strip on Mueller-Hinton agar supplemented with 5% defibrinated sheep blood according to Clinical and Laboratory Standards Institute.
RESULTS: Pacemaker-induced endocarditis due to Gordonia bronchialis infection was determined in an 88-year old woman. The patient was treated with ceftriaxone and ciprofloxacin until completing 6 weeks from the pacemaker explant with a good evolution.
CONCLUSION: The case presented supports the pathogenic role of Gordonia bronchialis as an opportunistic pathogen and highlights the high risk of suffering infections caused by environmental bacteria.
Copyright © 2020 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Actinomycetales; Bacteremia; Endocarditis; Gordonia; Marcapasos; Pacemaker

Mesh:

Substances:

Year:  2022        PMID: 35577444     DOI: 10.1016/j.eimce.2020.11.024

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin (Engl Ed)        ISSN: 2529-993X


  1 in total

1.  Gordonia crocea sp. nov. Isolated from Wound Infection After Pacemaker Implantation: Case Report and Literature Review.

Authors:  Zhulan Yang; Zhen Zhang; Ming Chen; Zhiyong Liu
Journal:  Infect Drug Resist       Date:  2022-06-07       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.